Nisa Investment Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19M Sell
40,252
-30,328
-43% -$15.3M 0.07% 168
2025
Q4
$33M Buy
70,580
+12,126
+21% +$5.63M 0.11% 105
2025
Q3
$24.9M Sell
58,454
-7,108
-11% -$2.75M 0.1% 138
2025
Q2
$25.1M Buy
65,562
+4,824
+8% +$1.74M 0.11% 137
2025
Q1
$21M Sell
60,738
-6,295
-9% -$2.02M 0.11% 163
2024
Q4
$20.1M Sell
67,033
-5,944
-8% -$2.08M 0.08% 186
2024
Q3
$29.7M Buy
72,977
+5,091
+7% +$1.86M 0.18% 120
2024
Q2
$21.8M Buy
67,886
+5,464
+9% +$1.78M 0.14% 154
2024
Q1
$20.8M Sell
62,422
-3,392
-5% -$1.04M 0.14% 162
2023
Q4
$17.8M Sell
65,814
-5,960
-8% -$1.47M 0.13% 174
2023
Q3
$17.7M Sell
71,774
-11,796
-14% -$3.23M 0.13% 171
2023
Q2
$25.4M Buy
83,570
+1,941
+2% +$540K 0.19% 118
2023
Q1
$21.5M Buy
81,629
+10,111
+14% +$2.57M 0.17% 134
2022
Q4
$17.2M Sell
71,518
-45
-0.1% -$10.1K 0.14% 175
2022
Q3
$13.2M Sell
71,563
-1,485
-2% -$296K 0.11% 196
2022
Q2
$12.3M Sell
73,048
-1,165
-2% -$250K 0.11% 202
2022
Q1
$18.6M Sell
74,213
-21,641
-23% -$5.43M 0.13% 155
2021
Q4
$23M Sell
95,854
-2,948
-3% -$721K 0.17% 132
2021
Q3
$24K Sell
98,802
-9,784
-9% -$2.39M 0.15% 131
2021
Q2
$22.4K Buy
108,586
+4,558
+4% +$929K 0.14% 142
2021
Q1
$19.6K Sell
104,028
-13,607
-12% -$2.4M 0.12% 159
2020
Q4
$19.3M Sell
117,635
-79,474
-40% -$11.6M 0.12% 181
2020
Q3
$24.6M Buy
197,109
+106,089
+117% +$13.1M 0.2% 117
2020
Q2
$8.83M Buy
91,020
+15,650
+21% +$1.63M 0.08% 235
2020
Q1
$6.77M Buy
75,370
+15,400
+26% +$1.99M 0.08% 238
2019
Q4
$8.86M Sell
59,970
-2,715
-4% -$365K 0.08% 245
2019
Q3
$7.55M Buy
62,685
+18,455
+42% +$2.38M 0.07% 279
2019
Q2
$5.98M Sell
44,230
-8,915
-17% -$1.13M 0.06% 324
2019
Q1
$6.93M Buy
53,145
+4,388
+9% +$589K 0.07% 282
2018
Q4
$6.07M Sell
48,757
-7,209
-13% -$968K 0.07% 273
2018
Q3
$7.79M Buy
55,966
+7,236
+15% +$901K 0.07% 265
2018
Q2
$5M Buy
48,730
+200
+0.4% +$20.2K 0.05% 351
2018
Q1
$4.73M Buy
48,530
+650
+1% +$63.1K 0.05% 358
2017
Q4
$4.21M Sell
47,880
-1,400
-3% -$112K 0.04% 382
2017
Q3
$3.92M Sell
49,280
-24,643
-33% -$1.98M 0.04% 391
2017
Q2
$6.39M Sell
73,923
-20,576
-22% -$1.74M 0.08% 276
2017
Q1
$8.41M Buy
94,499
+5,330
+6% +$444K 0.1% 218
2016
Q4
$6.6M Buy
89,169
+7,368
+9% +$552K 0.08% 256
2016
Q3
$6.19M Buy
81,801
+1,507
+2% +$115K 0.08% 261
2016
Q2
$6.18M Buy
80,294
+26,114
+48% +$2.06M 0.08% 263
2016
Q1
$4.23M Buy
54,180
+33,400
+161% +$2.33M 0.06% 331
2015
Q4
$1.41M Hold
20,780
0.02% 640
2015
Q3
$1.65M Buy
20,780
+800
+4% +$70.8K 0.03% 591
2015
Q2
$1.81M Sell
19,980
-5,000
-20% -$401K 0.03% 600
2015
Q1
$1.88M Buy
24,980
+4,150
+20% +$298K 0.03% 603
2014
Q4
$1.53M Hold
20,830
0.02% 649
2014
Q3
$1.47M Buy
20,830
+1,100
+6% +$72.7K 0.02% 643
2014
Q2
$1.11M Sell
19,730
-1,070
-5% -$56.5K 0.02% 765
2014
Q1
$1.09M Buy
20,800
+5,500
+36% +$274K 0.02% 760
2013
Q4
$730K Sell
15,300
-3,500
-19% -$162K 0.01% 904
2013
Q3
$804K Buy
18,800
+3,800
+25% +$148K 0.01% 853
2013
Q2
$541K Buy
+15,000
New +$580K 0.01% 985

Other funds holding HCA

Nisa Investment Advisors's HCA Position: Q1 2026 in Review

Nisa Investment Advisors reduced its HCA Healthcare (HCA) stake by 43% in Q1 2026, selling an estimated $15.3M and leaving 40,252 shares worth $19M. The position accounts for 0.07% of the portfolio, ranked #168.

Nisa Investment Advisors first reported a position in HCA in Q2 2013 and has held it in 52 quarters since. The position peaked at $33M in Q4 2025. 1,418 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Nisa Investment Advisors held 40,252 shares of HCA Healthcare worth $19M as of Q1 2026.
  • Nisa Investment Advisors sold 30,328 HCA Healthcare shares in Q1 2026, an estimated $15.3M.
  • HCA Healthcare made up 0.07% of Nisa Investment Advisors's portfolio in Q1 2026, its #168 holding.
  • Nisa Investment Advisors first reported a position in HCA Healthcare in Q2 2013 and has held it in 52 quarters since.
  • Nisa Investment Advisors's HCA Healthcare position peaked at $33M in Q4 2025.
  • 1,418 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.